Pharma chief defends 400% drug price rise as a ‘moral requirement’: The Financial Times

Filed Under: Costs, Health plans, Patients

Pharma chief defends 400% drug price rise as a ‘moral requirement’: The Financial Times

“A pharma executive has defended his decision to raise the price of an antibiotic mixture to more than $2,000 a bottle, arguing there was a ‘moral requirement to sell the product at the highest price,’” David Crow writes over at The Financial Times. “Last month, Nostrum Laboratories, a small Missouri-based drugmaker, more than quadrupled the […]

Drug price information: What did Medicare pay?

Filed Under: Costs, Providers, Regulators

We get excited about price information over here at Clearhealthcosts.com, and we like to share our wonky excitement with you. Here’s a site where Medicare’s prices for drugs covered under Part B of Medicare are collected. The current data set is from April 2013. Chemotherapy drugs, vaccines, steroids, antibiotics, vitamins, painkillers and the like. These […]